Cephalon soars on hostile bid from Valeant
March 30, 2011 at 11:49 AM EDT
Valeant offers $5.7 billion for Cephalon as it tries to push the biotech firm into definitive merger talks.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.